Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delay From First Symptoms in Patients Presenting With STEMI and Cardiogenic Shock: Insights From the DanGer Shock Trial.

Circulation. Cardiovascular interventions·2026
Same author

Risk of developing autoimmune and immune mediated disease following a diagnosis of myocarditis - a Danish nationwide register-based cohort study.

International journal of cardiology·2025
Same author

Increased dose of adenosine and the relationship between the resting full-cycle ratio and fractional flow reserve.

International journal of cardiology. Heart & vasculature·2025
Same author

Long-Term Outcomes of the DanGer Shock Trial.

The New England journal of medicine·2025
Same author

Systolic Blood Pressure and Microaxial Flow Pump-Associated Survival in Infarct-Related Cardiogenic Shock: A Post Hoc Analysis of the DanGer Shock Randomized Clinical Trial.

JAMA cardiology·2025
Same author

Effect of Microaxial Flow Pump on Hemodynamics in STEMI-Related Cardiogenic Shock.

Journal of the American College of Cardiology·2025

Related Experiment Video

Updated: Jun 21, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

[Hypertension and the heart].

Kristian Wachtell1, Niels Holmark Andersen, Tage Lysbo Svendsen

  • 1Rigshospitalet, Hjertecenteret, Hjertemedicinsk Klinik B, København Ø. kristian@wachtell.dk

Ugeskrift for Laeger
|August 13, 2009
PubMed
Summary

Treating left ventricular hypertrophy with angiotensin II receptor blockers significantly reduces cardiovascular risk. Lowering blood pressure, especially in patients with hypertension or atrial fibrillation, is crucial for preventing heart failure and improving outcomes.

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Related Experiment Videos

Last Updated: Jun 21, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Area of Science:

  • Cardiology
  • Hypertension Research
  • Cardiac Electrophysiology

Context:

  • Left ventricular hypertrophy (LVH) is a significant predictor of cardiovascular events.
  • Hypertension is a primary driver of LVH and heart failure.
  • Atrial fibrillation is increasingly recognized as cardiac target organ damage.

Purpose:

  • To review the prognostic importance of LVH as cardiac target organ damage.
  • To highlight the efficacy of angiotensin II receptor blockade in reducing LVH.
  • To emphasize the benefits of blood pressure reduction in preventing heart failure and managing atrial fibrillation.

Summary:

  • Angiotensin II receptor blockers are highly effective in reducing left ventricular mass, leading to decreased cardiovascular morbidity and mortality.
  • Blood pressure reduction, particularly in hypertensive individuals, significantly lowers the incidence of heart failure.
  • Atrial fibrillation management should incorporate blood pressure control (targeting <130/85 mmHg) and risk factor reduction, utilizing ACE inhibitors or ARBs.

Impact:

  • Effective management of LVH and hypertension can substantially reduce cardiovascular mortality.
  • Integrating atrial fibrillation as target organ damage necessitates guideline revisions for blood pressure management.
  • Optimizing hemodynamic status through targeted therapies like ACE inhibitors or ARBs improves patient prognosis.